Granules India plunges 3.5%; 3 observations from USFDA

Granules India has received three observations from the USFDA for its Jeedimetla, Hyderabad facility during a recent inspection.

Granules India plunged 3.5% to Rs.152.10 on BSE. The drug firm Granules India has received three observations from the USFDA for its Jeedimetla, Hyderabad facility during a recent inspection. The scrip opened at Rs. 156.8 and has touched a high and low of Rs. 157 and Rs. 148.85 respectively. So far 1155603(NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs. 3300.51 crore.

The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 164.45 on 01-Dec-2015 and a 52 week low of Rs. 73.3 on 19-Dec-2014. Last one week high and low of the scrip stood at Rs. 161.35 and Rs. 147 respectively.

The promoters holding in the company stood at 48.43 % while Institutions and Non-Institutions held 8.27 % and 43.3 % respectively.

The stock is currently trading above its 50 DMA.